Anti-SARS-CoV-2 antibody immunoreactivity profiles during COVID-19 recurrence

被引：0
|
作者：
Gomes Gouvea, Maria da Penha [1 ]
Moulaz, Isac Ribeiro [2 ]
Gouveia, Thayna Martins [2 ]
Monlevade Lanca, Karen Evelin [2 ]
de Paula Lacerda, Barbara Sthefany [2 ]
Thompson, Beatriz Paoli [2 ]
Polese, Jessica [3 ]
de Lima, Marina Deorce [2 ]
Ribeiro-Rodrigues, Rodrigo [4 ,5 ]
Mill, Jose Geraldo [6 ]
Valim, Valeria [7 ]
机构：
[1] Univ Fed Espirito Santo, Hosp Univ Cassiano Antonio Moraes, Vitoria, ES, Brazil
[2] Univ Fed Espirito Santo, Ctr Ciencias Saude, Vitoria, ES, Brazil
[3] Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Pneumol, Vitoria, ES, Brazil
[4] Dept Saude Estado Espirito Santo, Lab Saude Publ Estado Espirito Santo, Vitoria, ES, Brazil
[5] Univ Fed Espirito Santo, Ctr Ciencias Saude, Ctr Doencas Infecciosas, Vitoria, ES, Brazil
[6] Univ Fed Espirito Santo, Ctr Ciencias Saude, Dept Ciencias Fisiol, Vitoria, ES, Brazil
[7] Univ Fed Espirito Santo, Hosp Univ Cassiano Antonio Moraes, Div Reumatol, Vitoria, ES, Brazil
来源：
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL | 2022年 / 55卷
关键词：
COVID-19; SARS-CoV-2; Recurrence; Humoral Reactivity;
D O I：
10.1590/0037-8682-0106-2022
中图分类号：
R38 [医学寄生虫学]; Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ; 100103 ;
摘要：
Background: This study aimed to evaluate IgG and IgM levels in COVID-19 recurrence. Methods: The serum antibody levels and clinical data from 73 healthcare workers with SARS-CoV-2 divided into seroconverted (n=51) and non-seroconverted (n=22) groups were assessed. The presence of specific anti-nucleocapsid (anti-N) IgM and IgG for SARS-CoV-2 was evaluated. IgG antibodies to the SARS-CoV-2 spike receptor-binding domain were used to confirm non-seroconversion in all negative anti-N. Results: Four recurrent cases displayed mild symptoms and were non-seroconverted until the recurrence of symptoms. Conclusions: Undetectable anti-nucleocapsid IgM and IgG levels may be correlated with symptomatic COVID-19 recurrence.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] DATA ON ANTI-SARS-COV-2 ANTIBODIES (IGM/IGG) IN COVID-19 PATIENTS
    Coculescu, Bogdan-Ioan
    Pana, Marina
    Vladimirescu, Alexandru Filip
    Coculescu, Elena Claudia
    Popa, Mircea-loan
    ROMANIAN JOURNAL OF LEGAL MEDICINE, 2021, 29 (04): : 356 - 359
  • [32] Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19
    Ibarrondo, F. Javier
    Fulcher, Jennifer A.
    Yang, Otto O.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (11): : 1085 - 1087
  • [33] Evaluation of Anti-SARS-CoV-2 IgA in the Conjunctival Secretions of COVID-19 Patients
    Mahmoud, Hany
    Hamody, Ahmed
    Hefny, Hesham M.
    Tohamy, Dalia
    Awny, Islam
    CLINICAL OPHTHALMOLOGY, 2021, 15 : 1933 - 1937
  • [34] Anti-SARS-CoV-2 IgG levels in relation to disease severity of COVID-19
    Yan, Xiquan
    Chen, Guoqiang
    Jin, Zhaoxia
    Zhang, Zhongwei
    Zhang, Bing
    He, Jiangming
    Yin, Siqing
    Huang, Juanshu
    Fan, Maiying
    Li, Zhenyuan
    Chen, Fang
    Zeng, Yong
    Han, Xiaotong
    Zhu, Yimin
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (01) : 380 - 383
  • [35] Anti-SARS-CoV-2 antibody responses in convalescent plasma donors with varying clinical manifestation severity of COVID-19
    Grujic, Jasmina
    Bujandric, Nevenka
    Obradovic, Zorana Budakov
    Savic, Nebojsa
    Dolinaj, Vladimir
    VOJNOSANITETSKI PREGLED, 2022, 79 (12) : 1201 - 1208
  • [36] Anti-SARS-CoV-2 Antibody Level Is Associated with a History of COVID-19 Infection and mRNA Vaccination in Patients with Diabetes
    Hataul, Is Asma'ul Haq
    Soetedjo, Nanny Natalia M.
    Debora, Josephine
    Djauhari, Hofiya
    Tiara, Marita Restie
    Susandi, Evan
    Alisjahbana, Bachti
    Wisaksana, Rudi
    Permana, Hikmat
    VACCINES, 2023, 11 (09)
  • [37] Anti-SARS-CoV-2 IgG and Neutralizing Antibody Levels in Patients with Past COVID-19 Infection: A Longitudinal Study
    Dinc, Harika Oyku
    Demirci, Mehmet
    Ozdemir, Yusuf Emre
    Sirekbasan, Serhat
    Aktas, Ayse Nur
    Karaali, Ridvan
    Tok, Yesim Tuyji
    Ozbey, Dogukan
    Akcin, Ruveyda
    Gareayaghi, Nesrin
    Kuskucu, Mert Ahmet
    Midilli, Kenan
    Aygun, Gokhan
    Saribas, Suat
    Kocazeybek, Bekir
    BALKAN MEDICAL JOURNAL, 2022, 39 (03) : 172 - 177
  • [38] The impact of early anti-SARS-CoV-2 antibody production on the length of hospitalization stay among COVID-19 patients
    de Almeida, Dalziza Victalina
    Cezar, Priscila Alves
    Fernandes, Thais Freitas Barreto
    Schwarz, Marcos Gustavo Araujo
    Mendonca-Lima, Leila
    Giacoia-Gripp, Carmem Beatriz Wagner
    Cortes, Fernanda Heloise
    Guimaraes, Monick Lindenmeyer
    Pilotto, Jose Henrique
    De Sa, Nathalia Beatriz Ramos
    Cazote, Andressa da Silva
    Gomes, Larissa Rodrigues
    Borges Quintana, Marcel de Souza
    Ribeiro-Alves, Marcelo
    Coelho, Lara Esteves
    Geraldo, Kim Mattos
    Ribeiro, Maria Pia Diniz
    Cardoso, Sandra Wagner
    Grinsztejn, Beatriz
    Veloso, Valdilea G.
    Morgado, Mariza Goncalves
    MICROBIOLOGY SPECTRUM, 2023, 11 (06):
  • [39] The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination
    Benschop, Robert J.
    Tuttle, Jay L.
    Zhang, Lin
    Poorbaugh, Josh
    Kallewaard, Nicole L.
    Vaillancourt, Peter
    Crisp, Melissa
    Thi Ngoc Vy Trinh
    Freitas, Joshua J.
    Beasley, Stephanie
    Daniels, Montanea
    Haustrup, Natalie
    Higgs, Richard E.
    Nirula, Ajay
    Cohen, Myron S.
    Marovich, Mary
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (655)
  • [40] Association of Symptoms After COVID-19 Vaccination With Anti-SARS-CoV-2 Antibody Response in the Framingham Heart Study
    Hermann, Emilia A.
    Lee, Benjamin
    Balte, Pallavi P.
    Xanthakis, Vanessa
    Kirkpatrick, Beth D.
    Cushman, Mary
    Oelsner, Elizabeth
    JAMA NETWORK OPEN, 2022, 5 (10)
12345